Mark R. Harrigan

Mark Harrigan practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Mark Harrigan's NPI, 1336176585, was assigned on June 26, 2006. Mark Harrigan graduated from University of Washington School of Medicine in 1995. Mark Harrigan holds Alabama license 26016.

Mark Harrigan's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Mark Harrigan's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Mark Harrigan is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Mark Harrigan to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Harrigan practices, 3 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Mark Harrigan's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dmand AI has Mark Harrigan's licenses on file in 2 states: Alabama and New York.

CMS data shows 339 Medicare services from Mark Harrigan across 11 procedure codes in 2024, for 217 Medicare patients. Medicare paid $39,179 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 217 Medicare patients who saw Mark Harrigan in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Harrigan's median patient age at 66, with 59% women.

In 2024, Mark Harrigan wrote 68 Medicare Part D claims for 32 patients. 91% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $155 in total drug cost. In 2023, CMS named 35 claims across 2 drugs.

Mark Harrigan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 111 papers to Mark Harrigan, published from 2003 to 2025. 2017 was the busiest year, with 14. The most frequent topics are Intracranial Aneurysm, Stroke and Embolization, Therapeutic. Mark Harrigan has published most often in Neurosurgery. Mark Harrigan's most frequent co-authors are Christoph Johannes Griessenauer, MD, Paul M. Foreman, MD and Beverly Claire Walters, MD.

Dmand AI links Mark Harrigan to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Cerebral Hemorrhage, Intracranial Hemorrhages and Carotid Stenosis.

CMS Open Payments shows 36 general payments to Mark Harrigan from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 41% of the total. Siemens Medical Solutions USA, Inc. paid the most, $1,600.

Mark Harrigan graduated from University of Washington School of Medicine in 1995.